5 years ago

fool.com.au

Here’s why analysts rate this ASX biotech share a ‘buy’

5 years ago

finnewsnetwork.com.au

Megaport (ASX:MP1) see revenue up 10% quarter on quarter

5 years ago

investorinsight.com.au

White Rock Minerals provides company update

5 years ago

stockhead.com.au

Door rotates again at pot stock Elixinol with return of the founder as chair

5 years ago

miningnews.net

Poochera scoping study improved

5 years ago

stockhead.com.au

Engage:BDR made a big pile of money in a record March quarter

5 years ago

stockhead.com.au

3 advanced project developers still raising $$ and locking away crucial off-take deals

5 years ago

stockhead.com.au

Fintechs are telling shareholders to take a chill pill — and it seems to be working

5 years ago

finfeed.com

Navarre variances exploration success at Tandarra

5 years ago

stockhead.com.au

Gold tipped to make gains as global markets stumble